Transanal Endoscopic Microsurgery Following Treatment with Imatinib : a Case Report of a Patient with a Rectal Gastrointestinal Stromal Tumor

被引:1
作者
Tielen, R. [1 ,2 ]
Bremers, A. J. A. [1 ]
van der Graaf, W. T. A. [2 ]
Flucke, U. E. [3 ]
de Wilt, J. H. W. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Surg Oncol, NL-6525 GA Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 GA Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands
关键词
NEOADJUVANT IMATINIB; SURGICAL-MANAGEMENT; MUTATIONS; MESYLATE; GIST;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background : Gastrointestinal stromal tumors (GIST) of the rectum are a challenge for the colorectal surgeon. In case of a locally advanced rectal GIST, an extended or multivisceral resection with significant morbidity and mortality is often necessary. Literature is lacking on the combined modality of transanal endoscopisc microsurgery (TEM) following imatinib for these patients. Methods : We describe a combined approach for a locally advanced GIST of the rectum with preoperative imatinib treatment and subsequent local excision using the TEM procedure. Results : After six months of treatment with imatinib the TEM procedure was successfully performed with a radical resection of the remnant tumor. Twenty-four months after surgery this patient has no evidence of disease. Conclusion : A TEM procedure following treatment with imatinib may safely be performed in selected patients with a locally advanced GIST.
引用
收藏
页码:166 / 169
页数:4
相关论文
共 18 条
[1]  
BUESS G, 1984, CHIRURG, V55, P677
[2]   Gastrointestinal stromal tumours [J].
Connolly, EM ;
Gaffney, E ;
Reynolds, JV .
BRITISH JOURNAL OF SURGERY, 2003, 90 (10) :1178-1186
[3]   Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[4]   Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665 [J].
Eisenberg, Burton L. ;
Harris, Jonathan ;
Blanke, Charles D. ;
Demetri, George D. ;
Heinrich, Michael C. ;
Watson, James C. ;
Hoffman, John P. ;
Okuno, Scott ;
Kane, John M. ;
von Mehren, Margaret .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (01) :42-47
[5]  
FUJIMOTO Y., 2013, INT J COLORECTAL DIS
[6]   Surgical management of gastrointestinal stromal tumours [J].
Gervaz, P. ;
Huber, O. ;
Morel, P. .
BRITISH JOURNAL OF SURGERY, 2009, 96 (06) :567-578
[7]   PDGFRA activating mutations in gastrointestinal stromal tumors [J].
Heinrich, MC ;
Corless, CL ;
Duensing, A ;
McGreevey, L ;
Chen, CJ ;
Joseph, N ;
Singer, S ;
Griffith, DJ ;
Haley, A ;
Town, A ;
Demetri, GD ;
Fletcher, CDM ;
Fletcher, JA .
SCIENCE, 2003, 299 (5607) :708-710
[8]   Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].
Hirota, S ;
Isozaki, K ;
Moriyama, Y ;
Hashimoto, K ;
Nishida, T ;
Ishiguro, S ;
Kawano, K ;
Hanada, M ;
Kurata, A ;
Takeda, M ;
Tunio, GM ;
Matsuzawa, Y ;
Kanakura, Y ;
Shinomura, Y ;
Kitamura, Y .
SCIENCE, 1998, 279 (5350) :577-580
[9]  
Joensuu H., 2011, ASCO M, V29
[10]   Neoadjuvant imatinib in gastrointestinal stromal tumor of the rectum: Report of a case [J].
Lo, SS ;
Papachristou, GI ;
Finkelstein, SD ;
Conroy, WP ;
Schraut, WH ;
Ramanathan, RK .
DISEASES OF THE COLON & RECTUM, 2005, 48 (06) :1316-1319